Written answer
Departmental Strategies
179. Deputy Colm Burke asked the Minister for Foreign Affairs and Trade following on from her leadership on commencing a strategic dialogue with the life science industry under the Irish EU Presidency, her plans post this meeting to have her Department advance the strategic dialogue concept with the life sciences sector and formulate an EU Pharma Taskforce. [79643/26]
Comment on this
The life sciences sectors, encompassing pharmaceuticals and medtech and biotech, are absolutely essential for our global competitiveness, accounting for almost 10% of European GDP.
To ensure this crucial ecosystem remains vibrant and resilient, I convened a strategic dialogue on life sciences on the margins of the informal meeting of the Foreign Affairs Council on Trade or FAC (Trade), which I hosted in Dublin on 22 and 23 October. Bringing together the European Commissioner for Trade and Economic Security, Maroš Šefčovič, trade ministers from a number of EU Member States with significant pharmaceutical and medical devices sectors and key industry representatives from the sector allowed us to foster an open dialogue and facilitated a vital exchange of ideas. As trade ministers we bring a particular perspective to the issue, not least against the background of the changed international trading environment in recent times.
My ambition is that this strategic dialogue on life sciences will mark the beginning of a more structured, ongoing engagement both among policy makers and between policymakers and industry leaders. By working closely together, we can ensure that Europe's life sciences sector continues to innovate and deliver effectively for our citizens, communities, companies and jobs across the continent. I am in ongoing discussion with my trade minister counterparts on the next steps in achieving this ambition.